We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Elements in Molecular Oncology
About the Series
Therapeutics in clinical oncology are based increasingly on molecular drivers and hallmarks of cancers. Elements in Molecular Oncology provides a timely overview of topics in oncology for researchers and clinicians. By focusing on cancer sites or pathways, this series presents information on the latest findings on cancer causation and treatment.
About the Series Editor
Dr. Edward P. Gelmann is John Norton Professor of Prostate Cancer Research at the University of Arizona and the University of Arizona Cancer Center. Dr. Gelmann previously headed Divisions of Hematology/Oncology at both Georgetown University and Columbia University. He has been the recipient of NIH, DOD and NIEHS grants for his research that has spanned cancer basic, clinical, and population sciences. Dr. Gelmann’s research currently focuses on the early stages of prostate carcinogenesis and the development of novel therapeutics for prostate cancer. He continues to be involved in clinical care and clinical research of genitourinary malignancies. He has an active clinical practice and directs GU clinical research at the Cancer Center. Dr. Gelmann has published extensively and is senior editor of the book Molecular Oncology: Causes of Cancer and Targets for Treatment (Cambridge University Press, 2013).
